India clears Merck, Arkray's investment plans
This article was originally published in Scrip
Executive Summary
India has cleared foreign direct investment (FDI) proposals worth about INR39.51bn ($654m) across various industry sectors, including Merck & Co's plan to increase its holding in subsidiary Fulford India and the Japanese company Arkray's acquisition of the in vitro diagnostics (IVD) business of a local firm.